Overview

Fondaparinux Market is expected to grow at a high CAGR during the forecast period (2024-2031). 

Fondaparinux is a synthetic anticoagulant, commonly referred to as a blood thinner, used to prevent and treat blood clots in the legs, lungs, and other areas of the body. It works by inhibiting the action of thrombin, a key enzyme in blood clot formation. Administered via subcutaneous injection, fondaparinux is often combined with other medications to lower the risk of clotting.

Request for free sample:https://www.datamintelligence.com/download-sample/fondaparinux-market

Market Growth Trends

The growing burden of cardiovascular disease drives market growth    

Ischemic heart disease and stroke are the leading causes of death and disability globally, with cardiovascular diseases (CVDs) also contributing significantly to disability. According to a 2022 article published in the Journal of the American College of Cardiology, 1.87 million (95% CI: 1.44-2.34 million) cardiovascular deaths and 3.47 million (95% CI: 2.93-4.00 million) overall deaths were linked to reduced kidney function.

Most non-high-income countries continue to see a growing burden of CVD, and alarmingly, the age-standardized rate of CVD is beginning to rise in some high-income regions where it had previously been declining.  

Get your customized report @https://www.datamintelligence.com/customize/fondaparinux-market

Market is segmented

By Type:  Branded, Generic

By Application:  Orthopedics, Cardiovascular, Others

By End User:  Hospitals and Clinics, Diagnostic Centers, Ambulatory Surgical Centers

By Region:  North America, Latin America, Europe, Asia Pacific, Middle East, and Africa

Market Key Players

·         Dr. Reddy's Laboratories, Inc.

·         GlaxoSmithKline Plc

·         Mylan N.V.

·         Pfizer, Inc.

·         Bayer Healthcare AG

·         Boehringer Ingelheim

·         Sanofi S.A.

·         Abbott

·         Aspen Holdings

·         Bristol-Myers Squibb Company

Related Reports

Metrorrhagia Treatment Market

Fanconi Anemia Market  

Contact Us:

Company Name: DataM Intelligence

Email: info@datamintelligence.com

Contact Person: Sai. K

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About DataM Intelligence:

DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. At DataM Intelligence, we leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across